Solvay


Impairment-driven effects

25/06/20 -"We have factored in the potential c.€1.5bn impairment on the composites and (shale) oil & gas business, due to the subdued future business expectations. "

Pages
58
Language
English
Published on
25/06/20
You may also be interested by these reports :
14/08/20
We have slightly adjusted our FY2020 profitability expectations as the expected recovery in ASPs will not be strong enough to fill the ‘gap’. Despite ...

14/08/20
Against the background of the stronger than expected Q2 figures, we have made some adjustments to our profitability and have taken the higher than ...

13/08/20
Lockdowns do not always have to be something negative, by definition, as one could start a private cooking career or the beginning of the home ...

13/08/20
Lanxess’ cash pile remained quite high and the pattern of NWC flows gave us no clear indications. Q2 net earnings were positively impacted by the ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO